Ethical Dimensions of Management in the Biotechnology and Health Industry (3) Ethical managerial decision-making in biotechnology, pharmaceuticals, and health including ethical implications of technological/scientific advances, medical interventions, and business decisions.
BUSAD 534. Ethical Dimensions of Management in the Biotechnology and Health Industry (3)
BUSAD 534 introduces the students to various ethical decision-making frameworks, which are then applied to critically examine issues within the biotechnology and health industries. Ethical decision-making frameworks include utilitarian principles, rights and justice theories, virtue ethics, feminist ethics, and various medical ethics models. Applications to cases involving genetic testing, stem cell research, euthanasia, organ retrieval and transplantation, and pharmaceutical development are among those to be explored. Teaching methods include faculty lectures, case study analysis, small group and class discussions, and industry guest speaker presentations. Students will be evaluated on the quality of individual and team writing assignments as well as a team oral presentation. The course will be offered twice annually by the Penn State Great Valley School of Graduate Professional Studies' MBA program and is a required course in the Penn State Great Valley MBA program option biotechnology and health industry management.
Faculty member proposing course: Donald Snook
Note : Class size, frequency of offering, and evaluation methods will vary by location and instructor. For these details check the specific course syllabus.